Celldex Therapeutics, Inc.

DB:TCE2 Stock Report

Market Cap: €1.7b

Celldex Therapeutics, Inc. Company Information

Celldex Therapeutics, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Celldex Therapeutics, Inc.
  • Ticker: TCE2
  • Exchange: DB
  • Founded: 1983
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$1.792b
  • Listing Market Cap: US$1.712b
  • Shares Outstanding: 66.34m
  • Website: https://www.celldex.com

Number of Employees


Location

  • Celldex Therapeutics, Inc.
  • Perryville III Building
  • Suite 220
  • Hampton
  • New Jersey
  • 08827
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CLDXNasdaqCM (Nasdaq Capital Market)YesCommon Stock with Par Value 0.001USUSDMar 2008
TCE2DB (Deutsche Boerse AG)YesCommon Stock with Par Value 0.001DEEURMar 2008

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/12/12 12:30
End of Day Share Price 2024/12/12 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.